Loading…
The PD‐1/PD‐L1 axis may be aberrantly activated in occupational cholangiocarcinoma
Sato, Yasunori, Kinoshita, Masahiko, Takemura, Shigekazu, Tanaka, Shogo, Hamano, Genya, Nakamori, Shoji, Fujikawa, Masahiro, Sugawara, Yasuhiko, Yamamoto, Takatsugu, Arimoto, Akira, Yamamura, Minako, Sasaki, Motoko, Harada, Kenichi, Nakanuma, Yasuni, Kubo, Shoji
Published in Pathology international (01.03.2017)
Published in Pathology international (01.03.2017)
Get full text
Journal Article
Loading…
Prognostic Role of Plasma PD-1, PD-L1, pan-BTN3As and BTN3A1 in Patients Affected by Metastatic Gastrointestinal Stromal Tumors: Can Immune Checkpoints Act as a Sentinel for Short-Term Survival?
Fanale, Daniele, Incorvaia, Lorena, Badalamenti, Giuseppe, De Luca, Ida, Algeri, Laura, Bonasera, Annalisa, Corsini, Lidia Rita, Brando, Chiara, Russo, Antonio, Iovanna, Juan Lucio, Bazan, Viviana
Published in Cancers (27.04.2021)
Published in Cancers (27.04.2021)
Get full text
Journal Article
Loading…
How does the gut microbiome influence immune checkpoint blockade therapy?
Almonte, Andrew A, Rangarajan, Hareesha, Yip, Desmond, Fahrer, Aude M
Published in Immunology and cell biology (01.04.2021)
Published in Immunology and cell biology (01.04.2021)
Get more information
Journal Article
Loading…
Cancer immunotherapy by disrupting pd-1/pd-l1 signaling
COGSWELL John P, GUPTA Ashok K, WIGGINTON Jon M, JURE-KUNKEL Maria, WANG Xi-Tao, GOLDBERG Stacie M
Year of Publication 01.06.2025
Get full text
Year of Publication 01.06.2025
Patent
Loading…
Cancer immunotherapy by disrupting pd-1/pd-l1 signaling
COGSWELL John P, GUPTA Ashok K, WIGGINTON Jon M, JURE-KUNKEL Maria, WANG Xi-Tao, GOLDBERG Stacie M
Year of Publication 01.03.2025
Get full text
Year of Publication 01.03.2025
Patent
Loading…
Pd-1 / pd-l1 inhibitors for the treatment of cancer
Year of Publication 01.04.2024
Get full text
Patent
Loading…
Cancer immunotherapy by disrupting pd-1/pd-l1 signaling
COGSWELL John P, GUPTA Ashok K, WIGGINTON Jon M, JURE-KUNKEL Maria, WANG Xi-Tao, GOLDBERG Stacie M
Year of Publication 01.03.2022
Get full text
Year of Publication 01.03.2022
Patent
Loading…
Pd-1 / pd-l1 inhibitors for the treatment of cancer
Year of Publication 01.12.2023
Get full text
Patent
Loading…
Clinical Trial: A Study to Evaluate Enfortumab Vedotin (ASG-22CE) in Chinese Subjects With Locally Advanced or Metastatic Urothelial Cancer Who Previously Received Platinum-containing Chemotherapy and PD 1/PD-L1 Inhibitor Therapy
Published in US Fed News Service, Including US State News
(10.08.2021)
Get full text
Newsletter
Loading…
Cancer immunotherapy by disrupting pd-1/pd-l1 signaling
Year of Publication 01.02.2022
Get full text
Patent
Loading…
Loading…
Pd-1 / pd-l1 inhibitors for the treatment of cancer
Year of Publication 28.02.2021
Get full text
Patent
Loading…
Loading…
Loading…
Loading…
Loading…
Cancer immunotherapy by disrupting pd-1/pd-l1 signaling
Year of Publication 31.05.2018
Get full text
Patent
Loading…
Pd-1 / pd-l1 inhibitors for the treatment of cancer
Year of Publication 31.10.2017
Get full text
Patent
Loading…
Loading…